Nimagen - DNA Sequencing Technologies Partner

Company Overview:
NimaGen is a pioneering innovator in DNA sequencing technologies, trusted by laboratories in over 60 countries worldwide. Founded by scientists with a practical lab mindset, NimaGen specializes in developing next-generation sequencing (NGS) solutions powered by their proprietary Reverse Complement PCR (RC-PCR) technology. The company combines cutting-edge innovation with real-world lab practicality, offering both NGS-driven and Sanger sequencing solutions that eliminate vendor lock-in constraints.

Product Specialties & Applications:
NimaGen's comprehensive portfolio includes EasySeq™ NGS kits for microbiology and infectious disease detection, human genetics applications, and forensic analysis. Their RC-PCR technology delivers single-tube, multiplexed library preparation with superior sensitivity and specificity. Key product lines include NGS kits for 16S microbiome profiling, SARS-CoV-2 whole genome sequencing, and targeted genetic panels (BRCA1/2, CFTR); Sanger sequencing drop-in reagents for capillary electrophoresis with 30+ years of proven reliability; magnetic bead-based nucleic acid cleanup for optimal sample preparation; and IDseek® kits for forensic STR, SNP, and mitochondrial DNA profiling.

Alignment with Mega Life Science:
NimaGen's innovative NGS and Sanger sequencing solutions strengthen Mega Life Science's product portfolio for genomic research and diagnostics. By distributing NimaGen's RC-PCR technology and EasySeq™ kits, Mega Life Science offers customers cost-efficient, high-performance library preparation solutions with proven reliability across 60+ countries. This partnership enables Mega Life Science to provide comprehensive sequencing reagent options for human genetics, microbiology, and forensic applications, supporting laboratories at every stage of their genomic workflows.

Website: https://www.nimagen.com/